These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 30617806)

  • 1. Experimental Manipulation of Calpain Activity In Vitro.
    Kitagawa S
    Methods Mol Biol; 2019; 1915():209-218. PubMed ID: 30617806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calpain inhibitors stimulate phagocyte functions via activation of human formyl peptide receptors.
    Fujita H; Kato T; Watanabe N; Takahashi T; Kitagawa S
    Arch Biochem Biophys; 2011 Sep; 513(1):51-60. PubMed ID: 21723247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of human formyl peptide receptors by calpain inhibitors: homology modeling of receptors and ligand docking simulation.
    Fujita H; Kato T; Watanabe N; Takahashi T; Kitagawa S
    Arch Biochem Biophys; 2011 Dec; 516(2):121-7. PubMed ID: 22005393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptosis induced by novel aldehyde calpain inhibitors in human tumor cell lines.
    Guan N; Korukonda R; Hurh E; Schmittgen TD; Donkor IO; Dalton JT
    Int J Oncol; 2006 Sep; 29(3):655-63. PubMed ID: 16865282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New tripeptide-based macrocyclic calpain inhibitors formed by N-alkylation of histidine.
    Chen H; Jiao W; Jones MA; Coxon JM; Morton JD; Bickerstaffe R; Pehere AD; Zvarec O; Abell AD
    Chem Biodivers; 2012 Nov; 9(11):2473-84. PubMed ID: 23161629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calpastatin exon 1B-derived peptide, a selective inhibitor of calpain: enhancing cell permeability by conjugation with penetratin.
    Gil-Parrado S; Assfalg-Machleidt I; Fiorino F; Deluca D; Pfeiler D; Schaschke N; Moroder L; Machleidt W
    Biol Chem; 2003 Mar; 384(3):395-402. PubMed ID: 12715890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calpain-1 inhibitors for selective treatment of rheumatoid arthritis: what is the future?
    Miller DJ; Adams SE; Hallett MB; Allemann RK
    Future Med Chem; 2013 Nov; 5(17):2057-74. PubMed ID: 24215346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of a reported calpain inhibitor isolated from Streptomyces griseus.
    Donkor IO; Sanders ML
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2647-9. PubMed ID: 11551769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developments in the design and synthesis of calpain inhibitors.
    Neffe AT; Abell AD
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):684-700. PubMed ID: 16312145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel series of urea-based peptidomimetic calpain inhibitors.
    Sanders ML; Donkor IO
    Bioorg Med Chem Lett; 2006 Apr; 16(7):1965-8. PubMed ID: 16412635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptidyl aldehyde inhibitors of calpain incorporating P2-proline mimetics.
    Donkor IO; Korukonda R; Huang TL; LeCour L
    Bioorg Med Chem Lett; 2003 Mar; 13(5):783-4. PubMed ID: 12617890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the importance of the P2-P3-NHCO-moiety in a potent di- or tripeptide inhibitor of calpain I: insights into the development of nonpeptidic inhibitors of calpain I.
    Chatterjee S; Iqbal M; Mallya S; Senadhi SE; O'Kane TM; McKenna BA; Bozyczko-Coyne D; Kauer JC; Siman R; Mallamo JP
    Bioorg Med Chem; 1998 May; 6(5):509-22. PubMed ID: 9629465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpain inhibitor-induced apoptosis in human prostate adenocarcinoma cells.
    Zhu W; Murtha PE; Young CY
    Biochem Biophys Res Commun; 1995 Sep; 214(3):1130-7. PubMed ID: 7575520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of 4-aryl-4-oxobutanoic acid amides as calpain inhibitors.
    Zhang Y; Jung SY; Jin C; Kim ND; Gong P; Lee YS
    Bioorg Med Chem Lett; 2009 Jan; 19(2):502-7. PubMed ID: 19041242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure and physiological function of calpains.
    Sorimachi H; Ishiura S; Suzuki K
    Biochem J; 1997 Dec; 328 ( Pt 3)(Pt 3):721-32. PubMed ID: 9396712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antileishmanial activity of MDL 28170, a potent calpain inhibitor.
    d'Avila-Levy CM; Marinho FA; Santos LO; Martins JL; Santos AL; Branquinha MH
    Int J Antimicrob Agents; 2006 Aug; 28(2):138-42. PubMed ID: 16842979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An updated patent review of calpain inhibitors (2012 - 2014).
    Donkor IO
    Expert Opin Ther Pat; 2015 Jan; 25(1):17-31. PubMed ID: 25399719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The structural basis of differential inhibition of human calpain by indole and phenyl α-mercaptoacrylic acids.
    Adams SE; Rizkallah PJ; Miller DJ; Robinson EJ; Hallett MB; Allemann RK
    J Struct Biol; 2014 Sep; 187(3):236-241. PubMed ID: 25086406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, biological evaluation and molecular modelling of N-heterocyclic dipeptide aldehydes as selective calpain inhibitors.
    Jones MA; Morton JD; Coxon JM; McNabb SB; Lee HY; Aitken SG; Mehrtens JM; Robertson LJ; Neffe AT; Miyamoto S; Bickerstaffe R; Gately K; Wood JM; Abell AD
    Bioorg Med Chem; 2008 Jul; 16(14):6911-23. PubMed ID: 18571418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A survey of calpain inhibitors.
    Donkor IO
    Curr Med Chem; 2000 Dec; 7(12):1171-88. PubMed ID: 11032966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.